118 related articles for article (PubMed ID: 16887216)
1. Urotensin II is raised in acute myocardial infarction and low levels predict risk of adverse clinical outcome in humans.
Khan SQ; Bhandari SS; Quinn P; Davies JE; Ng LL
Int J Cardiol; 2007 May; 117(3):323-8. PubMed ID: 16887216
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
Meyer B; Huelsmann M; Wexberg P; Delle Karth G; Berger R; Moertl D; Szekeres T; Pacher R; Heinz G
Crit Care Med; 2007 Oct; 35(10):2268-73. PubMed ID: 17717488
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction.
Sandhu S; Har BJ; Aggarwal SG; Kavanagh KM; Ramadan D; Exner DV;
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S86-9. PubMed ID: 19250120
[TBL] [Abstract][Full Text] [Related]
6. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
[TBL] [Abstract][Full Text] [Related]
7. Oxygen-regulated protein 150 and prognosis following myocardial infarction.
Ng LL; O'Brien RJ; Quinn PA; Squire IB; Davies JE
Clin Sci (Lond); 2007 Jul; 112(9):477-84. PubMed ID: 17176249
[TBL] [Abstract][Full Text] [Related]
8. Comparison of N-terminal pro-brain natriuretic peptide versus electrophysiologic study for predicting future outcomes in patients with an implantable cardioverter defibrillator after myocardial infarction.
Yu H; Oswald H; Gardiwal A; Lissel C; Klein G
Am J Cardiol; 2007 Aug; 100(4):635-9. PubMed ID: 17697820
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
Kotanidou A; Karsaliakos P; Tzanela M; Mavrou I; Kopterides P; Papadomichelakis E; Theodorakopoulou M; Botoula E; Tsangaris I; Lignos M; Ikonomidis I; Ilias I; Armaganidis A; Orfanos SE; Dimopoulou I
Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of increased urotensin II levels in acute myocardial infarction.
Zhang X; Ye Y; Yang C; Gong H; Li Y; Zhang G; Yuan J; Zou Y
Discov Med; 2018 Aug; 26(141):7-20. PubMed ID: 30265851
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction.
Khan SQ; Quinn P; Davies JE; Ng LL
Heart; 2008 Jan; 94(1):40-3. PubMed ID: 17488769
[TBL] [Abstract][Full Text] [Related]
12. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction.
Palmer BR; Pilbrow AP; Frampton CM; Yandle TG; Skelton L; Nicholls MG; Richards AM
Eur Heart J; 2008 Oct; 29(20):2489-96. PubMed ID: 18757359
[TBL] [Abstract][Full Text] [Related]
13. Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction.
Giallauria F; Lucci R; De Lorenzo A; D'Agostino M; Del Forno D; Vigorito C
Age Ageing; 2006 Nov; 35(6):601-7. PubMed ID: 16951263
[TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
Kwon TG; Bae JH; Jeong MH; Kim YJ; Hur SH; Seong IW; Cho MC; Seung KB; Jang YS; Park SJ;
Int J Cardiol; 2009 Apr; 133(2):173-8. PubMed ID: 18281115
[TBL] [Abstract][Full Text] [Related]
15. Prognostic usefulness of anemia and N-terminal pro-brain natriuretic peptide in outpatients with systolic heart failure.
Schou M; Gustafsson F; Kistorp CN; Corell P; Kjaer A; Hildebrandt PR
Am J Cardiol; 2007 Nov; 100(10):1571-6. PubMed ID: 17996522
[TBL] [Abstract][Full Text] [Related]
16. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
[TBL] [Abstract][Full Text] [Related]
17. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
[TBL] [Abstract][Full Text] [Related]
18. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
19. Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation.
Sanchis J; Bosch X; Bodí V; Bellera N; Núñez J; Benito B; Ordóñez J; Consuegra L; Heras M; Llècer A
Heart; 2008 Mar; 94(3):311-5. PubMed ID: 17639094
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
